OpenClassActions

Patents

Patents Class Actions Explained for 2026: Who It Affects, Key Evidence, and What to Do Next

Learn who qualifies for patent class actions, what proof matters, and how to protect a claim in 2026.

How to Verify Patents Class Actions Claims in 2026: court filings and settlement notices, Evidence, and Red Flags

Check the PACER docket, compare the court notice dates, and confirm the patent number before filing.

Patents Class Actions FAQ for October 2026: Source-Checked Answers to Common Questions

See which drug overcharge classes cover you, what delays cost buyers, and what proof helps file.

Patents Class Actions 2026 Guide: eligibility, proof, and deadlines; Key Facts and Questions to Ask

Use this guide to ask the right questions before you join, file, or miss a patent claim deadline.

What Is New With Patents Class Actions in October 2026? Latest court filings and settlement notices and Key Takeaways

See which October patent filings and settlements allow a claim, and which ones only matter for investors to watch.

Patents Class Actions October 2026 Update: What Changed, Why It Matters, and What to Watch Next

See which October patent rulings could mean money for buyers and which mean no claim yet.

Restasis Eye Drop Patent Antitrust Class Action

The Restasis Eye Drop Patent Antitrust Class Action is a major antitrust lawsuit against Allergan, the pharmaceutical company that manufactured and...

Nike Training App Subscription Lawsuit Settlement Update

There is no currently active Nike Training App Subscription lawsuit settlement as of March 2026.

Class Action Claims Hims & Hers Telehealth Enrolled Users in Subscription Without Clear Notice

Customers of Hims & Hers are reporting that the telehealth company enrolled them in ongoing subscription services without clear disclosure of what they...

Class Action Claims Humira Maker AbbVie Used Patent Thicket to Block Biosimilar Competitors

A class action lawsuit brought by grocery workers, city officials, and police unions alleged that AbbVie, the maker of Humira, deliberately built a wall...

We use cookies to run this site, measure how it’s used, and show ads. Choose “Essentials only” to limit cookies to what the site needs to work. Privacy Policy.